Moxie Clinical: Comprehensive Company Profile
Background
Overview
Moxie Clinical is a boutique Clinical Research Organization (CRO) specializing in providing personalized clinical trial solutions for MedTech innovators. Established with a mission to deliver high-quality, tailored clinical research services, Moxie Clinical integrates seamlessly into research teams, enhancing trial efficiency and effectiveness. The company operates primarily in the United States, with its headquarters located in San Francisco, California.
Mission and Vision
- Mission: To deliver high-quality, personalized clinical trial solutions with agility, integrity, and deep scientific rigor.
- Vision: To provide turnkey clinical research services and bespoke supporting solutions for MedTech pioneers, ensuring fast-track success to market approval in North America and Asia Pacific.
Primary Area of Focus
Moxie Clinical focuses on simplifying clinical operations for emerging life sciences companies by offering end-to-end regulatory and development guidance, innovative technology-driven trial management, and flexible, cost-effective support. Their expertise spans full-service clinical trial design, management, and site coordination across various therapeutic areas, including neurology, ophthalmology, and cardiovascular research.
Industry Significance
In the rapidly evolving MedTech industry, Moxie Clinical plays a crucial role by enabling startups and established companies to navigate complex regulatory landscapes, manage costly trials, and build the necessary infrastructure to bring new products to market efficiently. Their personalized approach and deep industry knowledge make them a valuable partner in accelerating medical advancements.
Key Strategic Focus
Core Objectives
- Efficiency and Cost-Effectiveness: Streamlining clinical trial processes to reduce timelines and expenses.
- Regulatory Compliance: Providing comprehensive guidance to overcome compliance hurdles and optimize submissions.
- Technological Integration: Leveraging innovative technologies to enhance trial management and data analysis.
Areas of Specialization
- Therapeutic Areas: Specializing in neurology, ophthalmology, cardiovascular research, and more.
- Trial Phases: Experience across all trial phases, including First-in-Human (FIH), Phase I, II, III, IV, and post-market studies.
- Product Modalities: Expertise in medical devices, pharmaceuticals, biologics, digital health, diagnostics, and combination products.
Key Technologies Utilized
- AI-Powered Analytics: Employing artificial intelligence to analyze trial data for insights and decision-making.
- Decentralized Trial Capabilities: Implementing decentralized trial models to increase patient access and engagement.
- Risk-Based Monitoring: Utilizing risk-based monitoring strategies to ensure data quality and patient safety.
Primary Markets Targeted
Moxie Clinical primarily serves MedTech companies in North America and the Asia Pacific region, focusing on both emerging startups and established firms seeking to enhance their clinical trial operations.
Financials and Funding
Funding History
- Series A: In August 2023, Moxie Clinical raised $15.7 million in a Series A funding round.
- Series B: In September 2024, the company secured an additional $10 million in a Series B funding round, led by Lachy Groom and Signalfire, nearly tripling its valuation from the previous year.
Total Funds Raised
As of September 2024, Moxie Clinical has raised a total of $25.7 million in funding.
Notable Investors
- Lachy Groom: A solo venture capitalist who led the Series B funding round.
- Signalfire: A venture capital firm that participated in the Series B funding round.
Utilization of Capital
The funds raised are intended to support Moxie Clinical's expansion plans, enhance its technological capabilities, and strengthen its position in the clinical trial solutions market.
Pipeline Development
As a Clinical Research Organization, Moxie Clinical does not develop its own pipeline candidates. Instead, it collaborates with clients to support the development of their clinical trial pipelines across various therapeutic areas and trial phases.
Technological Platform and Innovation
Proprietary Technologies
- Moxie Suite: An integrated software platform that offers electronic health records (EHR), practice management, payments, scheduling, and customer relationship management (CRM) tools tailored for aesthetic services.
Significant Scientific Methods
- AI-Powered Analytics: Utilizing artificial intelligence to analyze trial data for insights and decision-making.
- Decentralized Trial Capabilities: Implementing decentralized trial models to increase patient access and engagement.
- Risk-Based Monitoring: Utilizing risk-based monitoring strategies to ensure data quality and patient safety.
Leadership Team
Jasmine Wilson: President & CEO of Moxie Clinical. Jasmine has been instrumental in leading the company's strategic direction and operational excellence. Under her leadership, Moxie Clinical has expanded its services and strengthened its position in the market.
Competitor Profile
Market Insights and Dynamics
The clinical trial solutions market is characterized by a growing demand for efficient, cost-effective, and technologically advanced services. Companies like Moxie Clinical are well-positioned to capitalize on this trend by offering integrated solutions that address the complexities of modern clinical trials.
Competitor Analysis
Moxie Clinical operates in a competitive landscape with several key players offering similar services. However, Moxie Clinical differentiates itself through its personalized approach, deep industry expertise, and comprehensive service offerings.
Strategic Collaborations and Partnerships
Moxie Clinical has developed a large network of neurology specialists, ophthalmologists, and cardiovascular specialists to collaborate on clinical projects and strategic partnerships.
Operational Insights
Moxie Clinical's operational strategy focuses on integrating seamlessly with client research teams, providing flexible and cost-effective support, and leveraging innovative technologies to enhance trial management and data analysis. This approach enables the company to deliver high-quality, personalized clinical trial solutions that meet the unique needs of each client.
Strategic Opportunities and Future Directions
Moxie Clinical is well-positioned to expand its market presence by leveraging its technological capabilities, deep industry expertise, and strategic partnerships. The company aims to continue supporting MedTech innovators in bringing new products to market efficiently and effectively.
